06/07/2017
Zealand Pharma files registration statement for proposed initial public offering of ADSs in the U.S.
Zealand Pharma (“Zealand” or the "Company") announces that it has today filed a Form F-1 Registration Statement for a proposed initial public offering of American Depositary Shares ("ADSs"). The Registration Statement relating to these securities has been filed with the U.S. Securities and Exchange Commission [...]
